WHO ICTRP trial
Topical cyclosporine 2% for herpetic interstitial keratitis
IRCT2015052112724N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015052112724N2 |
|---|---|
| Public title | Topical cyclosporine 2% for herpetic interstitial keratitis |
| Scientific title | Randomized controlled trial for evaluation of safety and efficacy of topical cyclosporine 2% versus topical prednisolone for treatment of herpetic interstitial keratitis |
| Primary sponsor | Vice chancellor for research, Isfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Herpetic interstitial keratitis. Herpesviral keratitis and keratoconjunctivitis;Herpesviral keratitis and keratoconjunctivitis |
| Interventions | Intervention 1: Group 1: Intervention group, treatment with topical Cyclosporine 2 % (provided by Sinadarou company) 1 gtt every 12 hours. Intervention 2: Group 2: Control group, treatment with topical prednisolone acetate 1% (Precord… |
| Registration date | Oct 28, 2015 |
| Target size | 48 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: